Executive summary: American Academy of Dermatology guidelines of care for the management of atopic dermatitis in adults with topical therapies

J Am Acad Dermatol. 2023 Jul;89(1):128-129. doi: 10.1016/j.jaad.2022.08.068. Epub 2023 Jan 7.

Abstract

These guidelines update the 2014 recommendations for management of atopic dermatitis in adults with topical therapies. A multidisciplinary workgroup employed best practices for guideline development, including a systematic review of the evidence and application of the Grading of Recommendations, Assessment, Development, and Evaluation approach for assessing the certainty of the evidence and formulating and grading recommendations. The evidence on atopic dermatitis treatment supported strong recommendations for the use of nonprescription moisturizers, topical calcineurin inhibitors, topical corticosteroids, and topical PDE-4 and JAK inhibitors. Conditional recommendations are made for the use of bathing and wet wrap therapy and against the use of topical antimicrobials, antiseptics, and antihistamines.

Keywords: JAK inhibitor; antihistamines; antimicrobials; atopic dermatitis; bathing; calcineurin inhibitors; corticosteroids; emollients; topicals; wet wraps.

Publication types

  • Systematic Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Calcineurin Inhibitors / therapeutic use
  • Dermatitis, Atopic* / drug therapy
  • Dermatologic Agents* / therapeutic use
  • Dermatology*
  • Glucocorticoids
  • Humans

Substances

  • Calcineurin Inhibitors
  • Dermatologic Agents
  • Glucocorticoids